Microbio Co Ltd (4128) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Microbio Co Ltd (4128) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$51.95 Million ≈ $1.64 Million USD) by net assets (NT$10.40 Billion ≈ $327.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Microbio Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Microbio Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 4128 current and long-term liabilities for a breakdown of total debt and financial obligations.

Microbio Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Microbio Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Citizens Financial Services Inc. Common Stock
NASDAQ:CZFS
0.049x
Companhia Brasileira de Distribuição
F:C1B2
-0.073x
Vátryggingafélag Íslands hf
IC:SKAGI
0.083x
E Split Corp Class A
TO:ENS
0.100x
NACCO Industries Inc
NYSE:NC
0.027x
Norwood Financial Corp
NASDAQ:NWFL
0.039x
Rossari Biotech Limited
NSE:ROSSARI
0.024x
Western New England Bancorp Inc
NASDAQ:WNEB
0.023x

Annual Cash Flow Conversion Efficiency for Microbio Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Microbio Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see 4128 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 NT$11.87 Billion
≈ $373.94 Million
NT$529.90 Million
≈ $16.69 Million
0.045x +871.28%
2023-12-31 NT$13.50 Billion
≈ $425.34 Million
NT$-78.15 Million
≈ $-2.46 Million
-0.006x -157.28%
2022-12-31 NT$14.01 Billion
≈ $441.34 Million
NT$141.57 Million
≈ $4.46 Million
0.010x +159.17%
2021-12-31 NT$13.84 Billion
≈ $436.15 Million
NT$53.98 Million
≈ $1.70 Million
0.004x -54.37%
2020-12-31 NT$12.85 Billion
≈ $404.91 Million
NT$109.82 Million
≈ $3.46 Million
0.009x +6.78%
2019-12-31 NT$9.04 Billion
≈ $284.89 Million
NT$72.36 Million
≈ $2.28 Million
0.008x +388.65%
2018-12-31 NT$9.68 Billion
≈ $304.91 Million
NT$15.85 Million
≈ $499.33K
0.002x +238.29%
2017-12-31 NT$8.30 Billion
≈ $261.53 Million
NT$-9.83 Million
≈ $-309.70K
-0.001x +94.47%
2016-12-31 NT$8.41 Billion
≈ $265.04 Million
NT$-180.25 Million
≈ $-5.68 Million
-0.021x -18.36%
2015-12-31 NT$8.94 Billion
≈ $281.77 Million
NT$-161.90 Million
≈ $-5.10 Million
-0.018x +1.39%
2014-12-31 NT$9.10 Billion
≈ $286.68 Million
NT$-167.04 Million
≈ $-5.26 Million
-0.018x +9.53%
2013-12-31 NT$8.70 Billion
≈ $274.25 Million
NT$-176.63 Million
≈ $-5.56 Million
-0.020x +3.13%
2012-12-31 NT$6.32 Billion
≈ $199.08 Million
NT$-132.36 Million
≈ $-4.17 Million
-0.021x +51.99%
2011-12-31 NT$6.23 Billion
≈ $196.39 Million
NT$-271.95 Million
≈ $-8.57 Million
-0.044x -142.24%
2010-12-31 NT$5.04 Billion
≈ $158.75 Million
NT$520.41 Million
≈ $16.40 Million
0.103x +211.97%
2009-12-31 NT$5.26 Billion
≈ $165.69 Million
NT$-485.10 Million
≈ $-15.28 Million
-0.092x -15.56%
2008-12-31 NT$1.79 Billion
≈ $56.53 Million
NT$-143.21 Million
≈ $-4.51 Million
-0.080x -8.41%
2007-12-31 NT$1.29 Billion
≈ $40.78 Million
NT$-95.30 Million
≈ $-3.00 Million
-0.074x -1038.56%
2006-12-31 NT$559.40 Million
≈ $17.62 Million
NT$4.39 Million
≈ $138.25K
0.008x --

About Microbio Co Ltd

TWO:4128 Taiwan Packaged Foods
Market Cap
$287.22 Million
NT$9.12 Billion TWD
Market Cap Rank
#15141 Global
#644 in Taiwan
Share Price
NT$15.50
Change (1 day)
-0.64%
52-Week Range
NT$15.50 - NT$28.55
All Time High
NT$158.18
About

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. It also involved in the trading of organic foods; sale of beverages; pr… Read more